# Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

> **NCT06008678** · NA · COMPLETED · sponsor: **Resvent Holding USA LTD** · enrollment: 146 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** RXiBreeze PAP System, Model RXiBreeze 20A

## Key facts

- **NCT ID:** NCT06008678
- **Lead sponsor:** Resvent Holding USA LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-22
- **Primary completion:** 2023-11-22
- **Final completion:** 2023-11-29
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06008678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06008678, "Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06008678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*